NCT00496951View on ClinicalTrials.gov

Vagal Tone and Neonatal Abstinence Syndrome

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Neonatal Abstinence SyndromeVagal Tone
Interventions
DEVICE

Vagal tone assessment

An EKG will be obtained using a Physio-control EKG monitor (R wave Electronics of Florida) in standard application, with three chest leads. The EKG data is inputted into a vagal tone monitor (Delta Biometrix, Bethesda MD) which computes vagal tone from the EKG signal. This data is then transferred to a disk which is analyzed off-line.

Trial Locations (1)

21224

Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT00496951 - Vagal Tone and Neonatal Abstinence Syndrome | Biotech Hunter | Biotech Hunter